Stryker Corp
NYSE:SYK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
293.94
392.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Stryker Corp
Wall Street
Price Targets
SYK Price Targets Summary
Stryker Corp
According to Wall Street analysts, the average 1-year price target for
SYK
is 419.14 USD
with a low forecast of 373.7 USD and a high forecast of 472.5 USD.
SYK Last Price Targets
Stryker Corp
The latest public price target was made on Oct 31, 2024 by
Joanne Wuensch
from
Citigroup
,
who expects
SYK
stock to
rise by 11%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Joanne Wuensch
Citigroup
|
411
USD
Upside 11% |
1 month ago
Oct 31, 2024
|
Stryker price target raised to $411 from $406 at Citi
TheFly
|
Richard Newitter
Truist Financial
|
380
USD
Upside 3% |
1 month ago
Oct 30, 2024
|
Stryker (SYK) PT Raised to $380 at Truist Securities
StreetInsider
|
Matt O'Brien
Piper Sandler
|
420
USD
Upside 14% |
1 month ago
Oct 30, 2024
|
Stryker (SYK) PT Raised to $420 at Piper Sandler
StreetInsider
|
|
Ryan Zimmerman
BTIG
|
394
USD
Upside 7% |
1 month ago
Oct 30, 2024
|
Stryker (SYK) PT Raised to $394 at BTIG
StreetInsider
|
Kyle Rose
Canaccord Genuity
|
400
USD
Upside 8% |
1 month ago
Oct 30, 2024
|
Stryker (SYK) PT Raised to $400 at Canaccord Genuity
StreetInsider
|
|
Richard Newitter
Truist Financial
|
370
USD
Upside 0% |
2 months ago
Oct 14, 2024
|
Stryker price target raised to $370 from $345 at Truist
TheFly
|
|
Matt O\'Brien
Piper Sandler
|
380
USD
Upside 3% |
3 months ago
Sep 10, 2024
|
Piper Sandler Reiterates Overweight Rating on Stryker (SYK)
StreetInsider
|
|
Ryan Zimmerman
BTIG
|
374
USD
Upside 1% |
3 months ago
Aug 28, 2024
|
Stryker price target raised to $374 from $360 at BTIG
TheFly
|
|
Richard Newitter
Truist Financial
|
345
USD
Downside 7% |
4 months ago
Aug 1, 2024
|
Stryker price target lowered to $345 from $364 at Truist
TheFly
|
|
Ryan Zimmerman
BTIG
|
360
USD
Downside 3% |
4 months ago
Jul 31, 2024
|
Stryker price target lowered to $360 from $372 at BTIG
TheFly
|
David Roman
Goldman Sachs
|
372
USD
Upside 1% |
6 months ago
May 30, 2024
|
Goldman Sachs Starts Stryker (SYK) at Neutral
StreetInsider
|
David Toung
Argus Research
|
380
USD
Upside 3% |
7 months ago
May 22, 2024
|
Stryker seeing higher sales and margins, says Argus
TheFly
|
Mike Matson
Needham
|
392
USD
Upside 6% |
7 months ago
May 22, 2024
|
Stryker upgraded to Buy from Hold at Needham
TheFly
|
|
Ryan Zimmerman
BTIG
|
366
USD
Downside 1% |
8 months ago
Apr 15, 2024
|
Stryker price target raised to $366 from $353 at BTIG
TheFly
|
|
Matt O'Brien
Piper Sandler
|
280
USD
Downside 24% |
1 year ago
Jan 31, 2023
|
Stryker price target raised to $280 from $250 at Piper Sandler
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SYK's stock price target?
Price Target
419.14
USD
According to Wall Street analysts, the average 1-year price target for
SYK
is 419.14 USD
with a low forecast of 373.7 USD and a high forecast of 472.5 USD.
What is Stryker Corp's Revenue forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
Stryker Corp's revenue is
9%.
The projected
CAGR
for the next 4 years is
9%.
What is Stryker Corp's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Stryker Corp's operating income is
9%.
The projected
CAGR
for the next 4 years is
16%.
What is Stryker Corp's Net Income forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Stryker Corp's net income is
10%.
The projected
CAGR
for the next 4 years is
18%.
You don't have any saved screeners yet
